These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11908241)

  • 1. Black-box warning for droperidol surprises pharmacists.
    Young D
    Am J Health Syst Pharm; 2002 Mar; 59(6):494, 497, 502-4. PubMed ID: 11908241
    [No Abstract]   [Full Text] [Related]  

  • 2. Droperidol, QT prolongation, and sudden death: what is the evidence?
    Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
    Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA use of the black box warning: time for reevaluation as a safety tool.
    Liang BA
    J Clin Anesth; 2002 Dec; 14(8):561-3. PubMed ID: 12565112
    [No Abstract]   [Full Text] [Related]  

  • 4. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases.
    Habib AS; Gan TJ
    Anesth Analg; 2003 May; 96(5):1377-1379. PubMed ID: 12707137
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA "black box" labeling.
    Meyer RJ
    Ann Emerg Med; 2003 Apr; 41(4):559-60. PubMed ID: 12658256
    [No Abstract]   [Full Text] [Related]  

  • 6. The black box warning.
    Abourjaily HM; Rosenberg M
    J Mass Dent Soc; 2002; 51(3):54-6. PubMed ID: 12380043
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of patients reason for FDA black box warning on droperidol.
    Habib AS; Gan TJ
    Anesth Analg; 2004 Feb; 98(2):552. PubMed ID: 14742409
    [No Abstract]   [Full Text] [Related]  

  • 8. Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system.
    Halloran K; Barash PG
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):423-7. PubMed ID: 20446348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA response to droperidol black box warning editorials.
    Rappaport BA
    Anesth Analg; 2008 May; 106(5):1585. PubMed ID: 18420886
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia.
    Habib AS; Gan TJ
    J Clin Anesth; 2008 Feb; 20(1):35-9. PubMed ID: 18346607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro: The Food and Drug Administration Black box warning on droperidol is not justified.
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1414-7. PubMed ID: 18420854
    [No Abstract]   [Full Text] [Related]  

  • 12. Droperidol in the emergency department: is it safe?
    Richards JR; Schneir AB
    J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Con: The black box warning on droperidol should not be removed (but should be clarified!).
    Ludwin DB; Shafer SL
    Anesth Analg; 2008 May; 106(5):1418-20. PubMed ID: 18420855
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long QT syndrome].
    Zbinden S
    Anaesthesist; 2006 Sep; 55(9):1006-7; author reply 1007-8. PubMed ID: 16897019
    [No Abstract]   [Full Text] [Related]  

  • 15. Droperidol: should the black box be light gray?
    Dershwitz M
    J Clin Anesth; 2002 Dec; 14(8):598-603. PubMed ID: 12565120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droperidol--behind the black box warning.
    Horowitz BZ; Bizovi K; Moreno R
    Acad Emerg Med; 2002 Jun; 9(6):615-8. PubMed ID: 12045077
    [No Abstract]   [Full Text] [Related]  

  • 17. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
    Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
    Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based review of the black-box warning for droperidol.
    Jackson CW; Sheehan AH; Reddan JG
    Am J Health Syst Pharm; 2007 Jun; 64(11):1174-86. PubMed ID: 17519460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?
    Gan TJ; White PF; Scuderi PE; Watcha MF; Kovac A
    Anesthesiology; 2002 Jul; 97(1):287. PubMed ID: 12131145
    [No Abstract]   [Full Text] [Related]  

  • 20. After the black box warning: dramatic changes in ED use of droperidol.
    Jacoby JL; Fulton J; Cesta M; Heller M
    Am J Emerg Med; 2005 Mar; 23(2):196. PubMed ID: 15765344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.